Thromboelastography to Assess Hemostatic Changes in Patients Undergoing Elective Cesarean Delivery.

Completed

Conditions studied: Hemorrhage

In brief

The purpose of the study is to assess the coagulation changes that occur in patients undergoing elective Cesarean delivery using thromboelastography (TEG). We will compare coagulation data to assess potential coagulation changes associated with hemoglobin changes before and after surgery, and related to estimated blood loss.

Key facts

Study ID

NCT00767832

Run by

Stanford University

People needed

60

Starts

2008-08-01

Expected to finish

2009-06-01

Last updated by the study team

2009-11-09

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• All obstetric patients with singleton pregnancies admitted to the labor and delivery unit at Lucile Packard Hospital who undergo elective Cesarean delivery.
• We will select 100 healthy ASA 1 patients with singleton pregnancies who are scheduled for uncomplicated elective Cesarean delivery, with no anticipated risk of obstetric hemorrhage.

You may not qualify if…

• Patients with underlying coagulation disorders.
• Patients with thrombocytopenia.
• Patients with pregnancy-induced hypertension, pre-eclampsia.
• Patients requiring the following medications prior to surgery: NSAIDS, aspirin, anticoagulants.
• Patients requiring non-elective Cesarean delivery.
• Patients with significant obstetric or medical disease.
• No patients <18 years of age will be recruited.

Where it is running

• Stanford University School of Medicine — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.